Community Rating

Community rating is a method used by insurance companies to determine the premium rates for health insurance policies based on the average risk of a group or community rather than the individual's risk. This means that everyone within a certain geographic area or demographic group pays the same premium regardless of their health status, age, gender, or other individual risk factors.

Some key features of community rating include:

  • Standardized premiums: Under community rating, insurance companies set the same premium rate for everyone in a given community or demographic group, regardless of their individual risk factors.

  • Risk pooling: Community rating is based on the concept of risk pooling, where a large group of people share the financial risks of healthcare expenses.

  • Non-discrimination: Community rating prohibits insurance companies from using an individual's health status or other personal characteristics to set premium rates.

  • Subsidies: Community rating may require subsidies from the government or other sources to make coverage affordable for everyone, particularly those with higher healthcare needs.

For example, suppose a health insurance company offers a community-rated policy in a particular state. The premium rate for this policy is set at $500 per month for all members of the community, regardless of age, gender, or health status. This means that a healthy 25-year-old will pay the same premium rate as a 60-year-old with a chronic illness.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.